Practical use of sevelamer in chronic kidney disease patients on dialysis in People’s Republic of China

References

• KongXZhangLZhangLMineral and bone disorder in Chinese dialysis patients: a multicenter studyBMC Nephrol201291311622994525
   PubMedGoogle Scholar
• BurkeSKAminNSIncertiCPloneMALeeJWSevelamer hydrochloride (Renagel), a phosphate-binding polymer, does not alter the pharmacokinetics of two commonly used antihypertensives in healthy volunteersJ Clin Pharmacol200141219920511210402
   PubMed Web of Science ®Google Scholar
• PloneMAPetersenJSRosenbaumDPBurkeSKSevelamer, a phosphate-binding polymer, is a non-absorbed compoundClin Pharmacokinet200241751752312083979
   PubMed Web of Science ®Google Scholar
• ChertowGMBurkeSKRaggiPTreat to Goal Working GroupSevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney Int200262124525212081584
   PubMed Web of Science ®Google Scholar
• OkaYMiyazakiMMatsudaHSevelamer hydrochloride dose-dependent increase in prevalence of severe acidosis in hemodialysis patients: analysis of nationwide statistical survey in JapanTher Apher Dial2014181374324499082
   PubMed Web of Science ®Google Scholar
• PaiABSheplerBMComparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implicationsPharmacotherapy200929555456119397463
   PubMed Web of Science ®Google Scholar
• BurkeSKSlatopolskyEAGoldbergDIRenagel, a novel calcium-and aluminium-free phosphate binder, inhibits phosphate absorption in normal volunteersNephrol Dial Transplant1997128164016449269642
   PubMed Web of Science ®Google Scholar
• ChenNWuXDingXSevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration studyNephrol Dial Transplant201429115216024151017
   PubMed Web of Science ®Google Scholar
• FangYDingXQZouJZShort-term efficacy of sevelamer hydrochloride on hyperphosphatemia in patients undergoing maintenance hemodialysisChinese Journal of Nephrology2012283183188
   Google Scholar
• WangCYShort-term efficacy analysis of sevelamer hydrochloride on hyperphosphatemia in patients undergoing maintenance hemodialysisChina Heath Care Nutrition2013231301302
   Google Scholar
• TanHZSongXXLiuCXEfficacy of sevelamer carbonate on hyperphosphatemia patients undergoing maintenance hemodialysisJournal of Xinjiang Medical University2013387984978
   Google Scholar
• HuangZYTreatment of hyperphosphatemia with sevelamer hydrochloride in renal disease patients with MHDContemporary Medicine201420236869
   Google Scholar
• HeYJLiYKeJTShort-term efficacy and Safety Observation of 4 different types phosphate bindersChin J Blood Purif20131211632634
   Google Scholar
• LuLHuFQGongJHSevelamer hydrochloride impact on the microinflammatory state in diabetic kidney disease patients with MHDClin Nephrol2014146376
   Google Scholar
• ZhaoYChengHLiSLEfficacy of sevelamer carbonate on C-Reactive protein, fetuin-A and FGF-23 in end stage renal disease patientsChinese Journal of Integrated Traditional and Western Nephrology2014159808811
   Google Scholar
• RuiHRZhaoYJLinWMHigh-flux dialyzers impact on serum phosphorus and PTH of patients undergoing maintenance hemodialysisJournal of the 4th Military Medical University2005267664
   Google Scholar
• GoldsmithDRScottLJCvetkovicRSPloskerGLSevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on HaemodialysisDrugs20086818510418081374
   PubMed Web of Science ®Google Scholar
• HuFBDietary pattern analysis: a new direction in nutritional epidemiologyCurr Opin Lipidol20021313911790957
   PubMed Web of Science ®Google Scholar
• UribarriJPhosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intakeSemin Dial200720429530117635818
   PubMed Web of Science ®Google Scholar
• RavindranVBrydenWLKornegayETPhytates: occurrence, bioavailability, and implications in poultry nutritionAvian Poultry Biol Rev199562125143
   Google Scholar
• LeeDBWallingMWBrautbarNIntestinal phosphate absorption: influence of vitamin D and non-vitamin D factorsAm J Physiol19862503 Pt 1G369G3732420210
   PubMedGoogle Scholar
• MohammedAGibneyMJTaylorTGThe effects of dietary levels of inorganic phosphorus, calcium and cholecalciferol on the digestibility of phytate-P by the chickBr J Nutr19916622512591662069
   PubMed Web of Science ®Google Scholar
• PeterlikMWassermanRHRegulation by vitamin D of intestinal phosphate absorptionHorm Metab Res19801252162196248445
   PubMed Web of Science ®Google Scholar
• PointillartAFontaineNThomassetMEffects of vitamin D on calcium regulation in vitamin-D-deficient pigs given a phytate-phosphorus dietBr J Nutr19865636616693676238
   PubMed Web of Science ®Google Scholar
• SnowJLBakerDHParsonsCMPhytase, citric acid, and 1 alpha- hydroxycholecalciferol improve phytate phosphorus utilization in chicks fed a corn-soybean meal dietPoult Sci20048371187119215285510
   PubMed Web of Science ®Google Scholar
• BobeckEAMeyerKMHelvigCPetkovichMCookMESevelamer hydrochloride binds phosphate released from phytate in chicks fed 1α-hydroxy cholecalciferolJ Ren Nutr2013231212722406121
   PubMed Web of Science ®Google Scholar
• BrandenburgVMSchlieperGHeussenNSerological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective studyNephrol Dial Transplant20102582672267920172849
   PubMed Web of Science ®Google Scholar
• NoordzijMKorevaarJCBoeschotenEWThe Kidney Disease Outcomes Quality Initiative(K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patientsAm J Kidney Dis200546592593216253734
   PubMed Web of Science ®Google Scholar
• BraunlinWZhorovEGuoABile acid binding to sevelamer HClKidney Int200262261161912110025
   PubMed Web of Science ®Google Scholar
• DengZPLuoFZLiLBSevelamer hydrochloride (Renagel) impact on the microinflammatory state of MHD patientsMedical Information20122510107
   Google Scholar
• YeunJYLevineRAMantadilokVKaysenGAC-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patientsAm J Kidney Dis200035346947610692273
   PubMed Web of Science ®Google Scholar
• SchinkeTAmendtCTrindlAPöschkeOMüller-EsterlWJahnen-DechentWThe serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasisJ Biol Chem19962713420789207968702833
   PubMed Web of Science ®Google Scholar
• ChertowGMBurkeSKRaggiPTreat to Goal Working GroupSevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney Int200262124525212081584
   PubMed Web of Science ®Google Scholar
• BarretoDVBarreto FdeCde CarvalhoABPhosphate binder impact on bone remodeling and coronary calcification-Results from the BRiC StudyNephron Clin Pract20081104c273c28319001830
   PubMed Web of Science ®Google Scholar
• NavaneethanSDPalmerSCCraigJCElderGJStrippoliGFBenefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trialsAm J Kidney Dis200954461963719692157
   PubMed Web of Science ®Google Scholar
• YiHCTangLHZhangXPExperimental Study on Bone Defect Treated by Combined Autologous Bona Marrow Transplantation, Cuttebone, and Sodium HyaluronateChinese Journal of Integrated Traditional and Western Medicine20113181122112321910349
   PubMedGoogle Scholar
• ShenYFShenJGZhuSDAdvance in pharmacological action of Cuttlebone, a traditional Chinese medicineChina Pharmaceuticals201019108789
   Google Scholar
• WuCWChiCFHeGYDetermination of 8 trace elements in mantle muscle and cuttlebone of sepiella maindroni by ICP-MS using microwave digestion for sample preparationSpectroscopy and Spectral Analysis200929123395339820210178
   PubMed Web of Science ®Google Scholar
• ZhuQXLiYDEffect Analysis of cuttlebone combined with sevelamer on hyperphosphatemia patients with uremia undergoing maintenance hemodialysisContemporary Medicine20131936103105
   Google Scholar
• LiJQLiXFZhouWWClinical study on Effects of sevelamer on calcium phosphorus metabolism in hemodialysis uremic patientsChinese Journal of Integrated Traditional and Western Nephrology2012133246247
   Google Scholar
• LiuLSHuGStudy on effect of cuttlebone on serum phosphorus and PTH in hemodialysis uremic patientsPractical Clinical Journal of Integrated Traditional Chinese and Western Medicine20055556
   Google Scholar
• GuoYXStudy on treating hyperphosphatemia with cuttlebone in peritoneal dialysis patientsZhejiang Clinical Medical Journal200810912361237
   Google Scholar
• ZhaoJChenXLZhangJFEffect of sevelamer hydrochloride on serum phosphorus in uremia patients with administration of calcitrio pulse therapy on SHPTHainan Medical Journal201223183738
   Google Scholar
• DingYCombination therapy on severe SHPT patients on dialysis with sevelamer hydrochloride and low dose calcitrio pulse therapyMedical Information20142766869
   Google Scholar
• LiuWHHuWBWangXRClinical Observation on treating secondary hyperparathyroidism in dialysis patients with low calcium dialysate combined with active vitamin D and sevelamer hydrochlorideChin J Blood Purif2014713493496
   Google Scholar
• DuYLiMLiJEffect of calcitrio combined with sevelamer hydrochloride on serum PTH in chronic renal failure patientsChinese Journal of Clinicians (electronic edition)2011052505507
   Google Scholar
• XuMJShaoJYEffect of sevelamer hydrochloride combined with hemodiafiltration on renal osteodystrophyChina Modern Doctor201452184547
   Google Scholar
• YeQZhangJWEffect of triple therapy on renal osteodystrophy and on the serum levels of IL-6 and IL-12Guangdong Medical Journal2012331522482249
   Google Scholar
• LiuZGRenLYRenSEStudy on treating renal osteodystrophy with low calcium dialysate combined with sevelamer hydrochloride and calcitrio pulse therapyChina Prac Med20149253031
   Google Scholar
• HernandezJDWesselingKSaluskyIBRole of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophySemin Dial200518429029516076350
   PubMed Web of Science ®Google Scholar
• OgataHKoiwaFShishidoKKinugasaECombination therapy with sevelamer hydrochloride and calcium carbonate in Japanese patients with long-term hemodialysis: alternative approach for optimal mineral managementTher Apher Dial200591111515828900
   PubMed Web of Science ®Google Scholar